Biotech Acquisition Co - SIC # 6726 - UNIT INVESTMENT TRUSTS, FACE-AMOUNT CERTIFICATE OFFICES, AND CLOS

Ticker Exchange SIC # Website Latest Ticker
BIOT Nasdaq 6726

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biotech Acquisition Co

Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/Prospectus to The Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc. - May 24th, 2022 1:13 pm
Blade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International Conference - May 18th, 2022 1:01 pm
Blade Therapeutics Presents Data from Phase 1 and Preclinical Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference - May 16th, 2022 1:01 pm
Biotech Acquisition Company and Blade Therapeutics, Inc. Announce Effectiveness of Registration Statement on Form S-4, Date of BAC's Extraordinary General Meeting to Approve Proposed Business Combination and Signing of Up to $75 million Committed Equity Facility - May 9th, 2022 10:10 pm
Biotech Acquisition Company Announces Filing of First Amendment to Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc. - Apr 4th, 2022 7:49 pm
Blade Therapeutics Announces Feedback from FDA on End-of-Phase 1 Data Package - Apr 4th, 2022 12:00 pm
Blade Therapeutics to Present Data from Preclinical and Phase 1 Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference - Mar 24th, 2022 12:00 pm
Biotech Acquisition Company Announces Public Filing of Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc. - Mar 16th, 2022 12:00 pm
Blade Therapeutics to Participate in Upcoming Investor Conferences - Mar 7th, 2022 1:00 pm
Receiving vaccinations ‘is part of the social contract we sign up for’ in communities: Doctor - Feb 14th, 2022 9:17 pm
World Finance Named a 2022 Top Workplaces USA Winner - Feb 1st, 2022 5:25 pm
Investors in World Acceptance (NASDAQ:WRLD) have made a solid return of 261% over the past five years - Jan 19th, 2022 2:51 pm
Blade Therapeutics Announces Successful Completion of Phase 1 Clinical Study that Evaluated Co-Administration of Cudetaxestat with Either of Two Approved Therapies for Idiopathic Pulmonary Fibrosis - Jan 12th, 2022 1:00 pm
Biotech Acquisition Company Announces Confidential Submission of Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc. - Jan 3rd, 2022 1:00 pm
URGENT: The M&A Firm is Investigating the Merger of Biotech Acquisition Company - BIOT - Nov 30th, 2021 12:12 am
MERGER ALERT – CBTX. MCFE, and BIOT: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies - Nov 18th, 2021 11:55 pm
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Biotech Acquisition Company Merger - Nov 17th, 2021 11:00 pm
Moore Kuehn Encourages MNR, DSAC, BIOT, and ZIXI Investors to Contact Law Firm - Nov 11th, 2021 3:15 pm
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Biotech Acquisition Company with Blade Therapeutics, Inc. - Nov 9th, 2021 8:32 pm
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Biotech Acquisition Company (Nasdaq - BIOT) - Nov 8th, 2021 11:11 pm